These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 16131610)

  • 1. EFFECTS OF THE GONADOTROPIN-RELEASING HORMONE AGONIST THERAPY ON GROWTH AND BODY MASS INDEX IN GIRLS WITH IDIOPATHIC CENTRAL PRECOCIOUS PUBERTY.
    Donbaloğlu Z; Bedel A; Çetiner EB; Singin B; Behram BA; Tuhan H; Parlak M
    Acta Endocrinol (Buchar); 2022; 18(2):181-186. PubMed ID: 36212259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth, bone maturation and ovarian size in girls with early and fast puberty (EFP) and effects of three years treatment with GnRH analogue (GnRHa).
    Alaaraj N; Soliman AT; De Sanctis V; Hamed N; Alyafai F; Ahmed S; Khalil A; Bedair E; Elawwa A
    Acta Biomed; 2022 Jan; 92(6):e2021333. PubMed ID: 35075088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can Body Mass Index Affect Height Growth at Menarche among Girls Receiving Treatment for Early Puberty? A Retrospective Study in Korean Girls.
    Lee SJ; Kim SY; Kim M
    Children (Basel); 2022 Jan; 9(1):. PubMed ID: 35053736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Approach to the Evaluation and Management of the Obese Child With Early Puberty.
    Tenedero CB; Oei K; Palmert MR
    J Endocr Soc; 2022 Jan; 6(1):bvab173. PubMed ID: 34909516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term efficacy of 1-month and 3-month gonadotropin-releasing hormone agonist depots in girls with central precocious puberty.
    Jeon MJ; Choe JW; Chung HR; Kim JH
    Ann Pediatr Endocrinol Metab; 2021 Sep; 26(3):171-177. PubMed ID: 34015908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of gonadotropin-releasing hormone analog treatment on final height in girls aged 6-10 years with central precocious and early puberty.
    Onat PŞ; Erdeve ŞS; Çetinkaya S; Aycan Z
    Turk Pediatri Ars; 2020; 55(4):361-369. PubMed ID: 33414653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal follow-up to near final height of auxological changes in girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analog and grouped by pretreatment body mass index level.
    Park J; Hwang TH; Kim YD; Han HS
    Ann Pediatr Endocrinol Metab; 2018 Mar; 23(1):14-20. PubMed ID: 29609441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of gonadotropin-releasing hormone agonists on anthropometric change in girls with central precocious puberty.
    Yoon JW; Park HA; Lee J; Kim JH
    Korean J Pediatr; 2017 Dec; 60(12):395-402. PubMed ID: 29302264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The different effects of gonadotropin-releasing hormone agonist therapy on body mass index and growth between normal-weight and overweight girls with central precocious puberty.
    Yang WJ; Ko KH; Lee KH; Hwang IT; Oh YJ
    Ann Pediatr Endocrinol Metab; 2017 Mar; 22(1):49-54. PubMed ID: 28443259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body mass index in girls with idiopathic central precocious puberty during and after treatment with GnRH analogues.
    Arcari AJ; Gryngarten MG; Freire AV; Ballerini MG; Ropelato MG; Bergadá I; Escobar ME
    Int J Pediatr Endocrinol; 2016; 2016():15. PubMed ID: 27499763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin-Releasing Hormone Agonist Therapy and Obesity in Girls.
    Shiasi Arani K; Heidari F
    Int J Endocrinol Metab; 2015 Jul; 13(3):e23085. PubMed ID: 26401141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of gonadotropin-releasing hormone agonist therapy on body mass index and growth in girls with idiopathic central precocious puberty.
    Anık A; Çatlı G; Abacı A; Böber E
    Indian J Endocrinol Metab; 2015; 19(2):267-71. PubMed ID: 25729690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone agonist with or without growth hormone.
    Jung MK; Song KC; Kwon AR; Chae HW; Kim DH; Kim HS
    Ann Pediatr Endocrinol Metab; 2014 Dec; 19(4):214-9. PubMed ID: 25654068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher prevalence of obesity and overweight without an adverse metabolic profile in girls with central precocious puberty compared to girls with early puberty, regardless of GnRH analogue treatment.
    Colmenares A; Gunczler P; Lanes R
    Int J Pediatr Endocrinol; 2014; 2014(1):5. PubMed ID: 24742263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pros and cons of GnRHa treatment for early puberty in girls.
    Willemsen RH; Elleri D; Williams RM; Ong KK; Dunger DB
    Nat Rev Endocrinol; 2014 Jun; 10(6):352-63. PubMed ID: 24709660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome after depot gonadotrophin-releasing hormone agonist treatment for central precocious puberty: effects on body mass index and final height.
    Traggiai C; Perucchin PP; Zerbini K; Gastaldi R; De Biasio P; Lorini R
    Eur J Endocrinol; 2005 Sep; 153(3):463-4. PubMed ID: 16131610
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of treatment with gonadotropin releasing hormone analogues in girls with idiopathic central precocious puberty].
    Ságodi L; Sólyom E; Lombay B; Almási A; Vámosi I
    Orv Hetil; 2012 Mar; 153(11):418-24. PubMed ID: 22390866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time to menarche and final height after histrelin implant treatment for central precocious puberty.
    Gillis D; Karavani G; Hirsch HJ; Strich D
    J Pediatr; 2013 Aug; 163(2):532-6. PubMed ID: 23485026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Impact of gonadotropin-releasing hormone analogs treatment on final height in girls with central precocious puberty].
    Chen SK; Fan X; Tang Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 May; 11(5):374-6. PubMed ID: 19470261
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.